The effectiveness of a real life dose reduction strategy for tumour necrosis factor inhibitors in ankylosing spondylitis and psoriatic arthritis (2016)

First Author: Fong W
Attributed to:  Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kew269

PubMed Identifier: 27354684

Publication URI: http://europepmc.org/abstract/MED/27354684

Type: Journal Article/Review

Parent Publication: Rheumatology

Issue: 10

ISSN: 1462-0324